Skip to content
Triomics

GTM Leader, Biopharma/Life Sciences

New York Office Hybrid · United States
FullTime · Sales
POSTED 22 JULVERIFIED 1D AGO
Apply Ask
Role
110 days opentrue age
Posted 22 Jul
Pay
$113k–$125kno pay posted
$75k$175k
Market p25–p75
$75k–$175k
Triomics p25–p75
$113k–$125kn=3
New York · n=2353 · 365d to 6 Nov
CompanyTriomics →
14open roles
Opened · 30d
+0
Closed · 30d
−0
3d of snapshots · 30d window
Market
416,797open · Other
Opened · 7d
+21,5655% of open
All other
624,338open
All tracked boards · live 10 Nov · n=416,797

About Triomics

Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like matching patients to the right clinical trials, preparing for upcoming visits, and quality reporting. We replace that manual effort with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time.

Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, along with several of the largest community oncology practices. We have grown 10x over the last year and now process millions of oncology medical documents each month.

The Role

We're making our first commercial hire focused on biopharma. This is a build role. You will map a brand-new market, define how Triomics sells into life sciences, and stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals. Triomics builds oncology AI for the country's leading cancer centers. Our fully EMR-integrated platform turns dense patient charts into structured clinical data and matches patients to trials. We recently closed a Series B and are scaling from a handful to 25+ enterprise logos. Biopharma is a major part of where we grow next, and right now it's a blank sheet.

The best person for this role has spent their career selling into pharma or biopharma, specifically to clinical operations buyers, the people running trials day to day, not clinical development or commercial teams, and has a real book of relationships to show for it: sponsors you've sold before, who you sold, and what you sold them. You'll own the strategy first. You'll also carry it through to the sale, with a compensation structure built to reward what you close.

We're not anchoring this to a specific title or level up front. What matters is the scope of what you've sold and who you've sold it to; we'll work out leveling together once we've talked.

What You'll Do

Build the biopharma motion from zero

Map the biopharma and life sciences market: where we fit, what to sell, who to sell it to

Define the strategy for landing our first accounts, then the repeatable motion behind it

Run the full cycle once you've built it: prospecting, discovery, demos with our team, proposal, and close

Land a first use case, then grow it across the account

Be strategic and credible with life sciences buyers

Translate what our oncology AI does into the language of clinical development, real-world data, and trial operations

Build relationships across the buying group: clinical, data, operations, and procurement

Bring a consultative, structured approach to complex, multi-stakeholder deals

Own the sale, not just the strategy

Carry the deals you build through to closed and expanded

Keep a clean, current pipeline and forecast

This is where the variable side of your comp lives: you're incented on actually closing

Be a force multiplier across the company

Feed the market back into Product: what biopharma needs, what's landing, what's missing

Partner with the team on deal strategy and account planning

Coordinate with the cancer center side of the business on shared accounts

What Success Looks Like (First 90 Days)

You've mapped the biopharma market and have a clear view of your top targets

You have a qualified pipeline built and a point of view on what we sell and to whom

You've translated the product into a biopharma value story that resonates in discovery calls

You're running deals independently with clean forecasting

You've closed or meaningfully advanced at least one land opportunity

Leadership trusts you to own the function and represent Triomics to sophisticated buyers

Must-haves

10+ years selling into biopharma, pharma, or life sciences, with a track record selling specifically to clinical operations buyers, not clinical development or commercial-phase teams

Source · TriomicsFirst seen 3 Nov1 editsOriginal ↗